Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene

Christopher H. van Dyck, Robert T. Malison, Leslie K. Jacobsen, John P. Seibyl, Julie K. Staley, Marc Laruelle, Ronald M. Baldwin, Robert B. Innis and Joel Gelernter
Journal of Nuclear Medicine May 2005, 46 (5) 745-751;
Christopher H. van Dyck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert T. Malison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie K. Jacobsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Seibyl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie K. Staley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Laruelle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald M. Baldwin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert B. Innis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Gelernter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Transaxial 123I-β-CIT SPECT image at level of striatum. Scan demonstrates ROIs positioned over right and left caudate, right and left putamen, and occipital cortex. Representative attenuation ellipse is also displayed.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Striatal DAT availability (V3″) vs. age (in years) as measured by 123I-β-CIT SPECT in 94 healthy European Americans grouped according to SLC6A3 VNTR genotype. SLC6A3∗9R carriers (n = 41) had significantly higher striatal DAT availability (V3″) than did SLC6A3∗10R homozygotes (n = 53), controlling for age (F1,93 = 6.25, P = 0.014, ANCOVA). Both genotypic subgroups showed similar aging effects: For ∗9R carriers, V3″ declined by 44% over age range 18–88 y, or approximately 6.3% per decade. For ∗10R homozygotes, V3″ declined by 43% over age range 18–88 y, or approximately 6.2% per decade.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    DAT availability (V3″) in caudate (A) and putamen (B) vs. age (in years) as measured by 123I-β-CIT SPECT in 94 healthy European Americans grouped according to SLC6A3 VNTR genotype. SLC6A3∗9R carriers (n = 41) had significantly higher DAT availability (V3″) in both caudate (F1,93 = 4.88, P = 0.030, ANCOVA) and putamen (F1,93 = 6.92, P = 0.010, ANCOVA), controlling for age.

Tables

  • Figures
    • View popup
    TABLE 1

    Frequencies of VNTR Polymorphism of DAT Gene (SLC6A3) in Healthy European Americans

    FrequencyGenotype (VNTR)n%
    Observed10–105356
    9–103638
    9–955
    Expected10–1053.657
    9–1034.737
    9–95.66
    χ20.12
    df2
    P0.94
    • Two subjects with rare genotypes (7–10 and 10–11) are not included in table.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (5)
Journal of Nuclear Medicine
Vol. 46, Issue 5
May 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene
Christopher H. van Dyck, Robert T. Malison, Leslie K. Jacobsen, John P. Seibyl, Julie K. Staley, Marc Laruelle, Ronald M. Baldwin, Robert B. Innis, Joel Gelernter
Journal of Nuclear Medicine May 2005, 46 (5) 745-751;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene
Christopher H. van Dyck, Robert T. Malison, Leslie K. Jacobsen, John P. Seibyl, Julie K. Staley, Marc Laruelle, Ronald M. Baldwin, Robert B. Innis, Joel Gelernter
Journal of Nuclear Medicine May 2005, 46 (5) 745-751;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • ADHD: relation between cognitive characteristics and DAT1 / DRD4 dopamine polymorphisms
  • Dopaminergic Role in Regulating Neurophysiological Markers of Sleep Homeostasis in Humans
  • Gene x Abstinence Effects on Drug Cue Reactivity in Addiction: Multimodal Evidence
  • Multilocus Genetic Composite Reflecting Dopamine Signaling Capacity Predicts Reward Circuitry Responsivity
  • Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans
  • Variation in dopamine genes influences responsivity of the human reward system
  • Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3
  • Gene gene interaction associated with neural reward sensitivity
  • Additive Effects of Genetic Variation in Dopamine Regulating Genes on Working Memory Cortical Activity in Human Brain
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire